As far back as 2016, when BPC-157 started showing up as a potential doping problem, researchers had developed a method of detecting it at part-per-trillion levels in urine
Lets talk about whats possible
Good candidates Researchers studying anti-aging interventions Those investigating wound healing acceleration Researchers exploring hair and skin improvements Those combining with other peptides in tissue repair stacks Researchers with experience handling injectable compounds Poor candidates Individuals with Wilson's disease or copper metabolism disorders Those with active cancer or history of hormone-sensitive cancers (until more research exists) Pregnant or breastfeeding individuals Those taking anticoagulant medications (potential interaction concerns) Individuals with known copper allergies or sensitivities Anyone uncomfortable with self-injection or unable to maintain sterile technique When uncertain, consult a healthcare provider familiar with peptide research before beginning any protocol
Cagrilintide Dosage with Retatrutide: The Theoretical Framework Why Consider Combining These Peptides
When testosterone has undergone refrigeration, it tends to separate after crystallization
Real-world dosing and outcomes 6-month persister loss about 12-13% (Hankosky DOM 2025), broad-cohort about -9.8% (Adamidis Cureus 2026), telehealth completers near -23% (Duncan Obesity Pillars 2026)